Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Medicine for Osteoarthritis Pain market report explains the definition, types, applications, major countries, and major players of the Medicine for Osteoarthritis Pain market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Mylan
Bayer
TEVA
Iroko Pharmaceuticals
Johnson & Johnson
Abiogen Pharma
Astellas Pharma
Horizon Pharma
Pfizer
GlaxoSmithKline
Hengrui Pharmaceutical
Novartis
Abbott
Tide Pharmaceutical
Sanofi
Eli Lilly
Daiichi Sankyo
Almatica Pharma
By Type:
Oral
Injection
External
By End-User:
Medical Care
Personal Care
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Medicine for Osteoarthritis Pain Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Medicine for Osteoarthritis Pain Outlook to 2028- Original Forecasts
-
2.2 Medicine for Osteoarthritis Pain Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Medicine for Osteoarthritis Pain Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Medicine for Osteoarthritis Pain Market- Recent Developments
-
6.1 Medicine for Osteoarthritis Pain Market News and Developments
-
6.2 Medicine for Osteoarthritis Pain Market Deals Landscape
7 Medicine for Osteoarthritis Pain Raw Materials and Cost Structure Analysis
-
7.1 Medicine for Osteoarthritis Pain Key Raw Materials
-
7.2 Medicine for Osteoarthritis Pain Price Trend of Key Raw Materials
-
7.3 Medicine for Osteoarthritis Pain Key Suppliers of Raw Materials
-
7.4 Medicine for Osteoarthritis Pain Market Concentration Rate of Raw Materials
-
7.5 Medicine for Osteoarthritis Pain Cost Structure Analysis
-
7.5.1 Medicine for Osteoarthritis Pain Raw Materials Analysis
-
7.5.2 Medicine for Osteoarthritis Pain Labor Cost Analysis
-
7.5.3 Medicine for Osteoarthritis Pain Manufacturing Expenses Analysis
8 Global Medicine for Osteoarthritis Pain Import and Export Analysis (Top 10 Countries)
-
8.1 Global Medicine for Osteoarthritis Pain Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Medicine for Osteoarthritis Pain Export by Region (Top 10 Countries) (2017-2028)
9 Global Medicine for Osteoarthritis Pain Market Outlook by Types and Applications to 2022
-
9.1 Global Medicine for Osteoarthritis Pain Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Oral Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Injection Consumption and Growth Rate (2017-2022)
-
9.1.3 Global External Consumption and Growth Rate (2017-2022)
-
9.2 Global Medicine for Osteoarthritis Pain Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Medical Care Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Personal Care Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Medicine for Osteoarthritis Pain Market Analysis and Outlook till 2022
-
10.1 Global Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.2.2 Canada Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.2.3 Mexico Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.3.2 UK Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.3.3 Spain Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.3.4 Belgium Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.3.5 France Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.3.6 Italy Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.3.7 Denmark Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.3.8 Finland Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.3.9 Norway Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.3.10 Sweden Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.3.11 Poland Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.3.12 Russia Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.3.13 Turkey Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.4.2 Japan Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.4.3 India Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.4.4 South Korea Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.4.5 Pakistan Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.4.6 Bangladesh Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.4.7 Indonesia Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.4.8 Thailand Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.4.9 Singapore Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.4.10 Malaysia Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.4.11 Philippines Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.4.12 Vietnam Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.5.2 Colombia Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.5.3 Chile Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.5.4 Argentina Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.5.5 Venezuela Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.5.6 Peru Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.5.7 Puerto Rico Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.5.8 Ecuador Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.6.2 Kuwait Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.6.3 Oman Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.6.4 Qatar Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.6.5 Saudi Arabia Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.6.6 United Arab Emirates Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.7.2 South Africa Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.7.3 Egypt Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.7.4 Algeria Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Medicine for Osteoarthritis Pain Consumption (2017-2022)
-
10.8.2 New Zealand Medicine for Osteoarthritis Pain Consumption (2017-2022)
11 Global Medicine for Osteoarthritis Pain Competitive Analysis
-
11.1 Mylan
-
11.1.1 Mylan Company Details
-
11.1.2 Mylan Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Mylan Medicine for Osteoarthritis Pain Main Business and Markets Served
-
11.1.4 Mylan Medicine for Osteoarthritis Pain Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Bayer
-
11.2.1 Bayer Company Details
-
11.2.2 Bayer Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Bayer Medicine for Osteoarthritis Pain Main Business and Markets Served
-
11.2.4 Bayer Medicine for Osteoarthritis Pain Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 TEVA
-
11.3.1 TEVA Company Details
-
11.3.2 TEVA Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 TEVA Medicine for Osteoarthritis Pain Main Business and Markets Served
-
11.3.4 TEVA Medicine for Osteoarthritis Pain Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Iroko Pharmaceuticals
-
11.4.1 Iroko Pharmaceuticals Company Details
-
11.4.2 Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Main Business and Markets Served
-
11.4.4 Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Johnson & Johnson
-
11.5.1 Johnson & Johnson Company Details
-
11.5.2 Johnson & Johnson Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Johnson & Johnson Medicine for Osteoarthritis Pain Main Business and Markets Served
-
11.5.4 Johnson & Johnson Medicine for Osteoarthritis Pain Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Abiogen Pharma
-
11.6.1 Abiogen Pharma Company Details
-
11.6.2 Abiogen Pharma Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Abiogen Pharma Medicine for Osteoarthritis Pain Main Business and Markets Served
-
11.6.4 Abiogen Pharma Medicine for Osteoarthritis Pain Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Astellas Pharma
-
11.7.1 Astellas Pharma Company Details
-
11.7.2 Astellas Pharma Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Astellas Pharma Medicine for Osteoarthritis Pain Main Business and Markets Served
-
11.7.4 Astellas Pharma Medicine for Osteoarthritis Pain Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Horizon Pharma
-
11.8.1 Horizon Pharma Company Details
-
11.8.2 Horizon Pharma Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Horizon Pharma Medicine for Osteoarthritis Pain Main Business and Markets Served
-
11.8.4 Horizon Pharma Medicine for Osteoarthritis Pain Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Pfizer
-
11.9.1 Pfizer Company Details
-
11.9.2 Pfizer Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Pfizer Medicine for Osteoarthritis Pain Main Business and Markets Served
-
11.9.4 Pfizer Medicine for Osteoarthritis Pain Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 GlaxoSmithKline
-
11.10.1 GlaxoSmithKline Company Details
-
11.10.2 GlaxoSmithKline Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 GlaxoSmithKline Medicine for Osteoarthritis Pain Main Business and Markets Served
-
11.10.4 GlaxoSmithKline Medicine for Osteoarthritis Pain Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Hengrui Pharmaceutical
-
11.11.1 Hengrui Pharmaceutical Company Details
-
11.11.2 Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Main Business and Markets Served
-
11.11.4 Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Novartis
-
11.12.1 Novartis Company Details
-
11.12.2 Novartis Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Novartis Medicine for Osteoarthritis Pain Main Business and Markets Served
-
11.12.4 Novartis Medicine for Osteoarthritis Pain Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Abbott
-
11.13.1 Abbott Company Details
-
11.13.2 Abbott Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Abbott Medicine for Osteoarthritis Pain Main Business and Markets Served
-
11.13.4 Abbott Medicine for Osteoarthritis Pain Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Tide Pharmaceutical
-
11.14.1 Tide Pharmaceutical Company Details
-
11.14.2 Tide Pharmaceutical Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Tide Pharmaceutical Medicine for Osteoarthritis Pain Main Business and Markets Served
-
11.14.4 Tide Pharmaceutical Medicine for Osteoarthritis Pain Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Sanofi
-
11.15.1 Sanofi Company Details
-
11.15.2 Sanofi Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Sanofi Medicine for Osteoarthritis Pain Main Business and Markets Served
-
11.15.4 Sanofi Medicine for Osteoarthritis Pain Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Eli Lilly
-
11.16.1 Eli Lilly Company Details
-
11.16.2 Eli Lilly Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Eli Lilly Medicine for Osteoarthritis Pain Main Business and Markets Served
-
11.16.4 Eli Lilly Medicine for Osteoarthritis Pain Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Daiichi Sankyo
-
11.17.1 Daiichi Sankyo Company Details
-
11.17.2 Daiichi Sankyo Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Daiichi Sankyo Medicine for Osteoarthritis Pain Main Business and Markets Served
-
11.17.4 Daiichi Sankyo Medicine for Osteoarthritis Pain Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 Almatica Pharma
-
11.18.1 Almatica Pharma Company Details
-
11.18.2 Almatica Pharma Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 Almatica Pharma Medicine for Osteoarthritis Pain Main Business and Markets Served
-
11.18.4 Almatica Pharma Medicine for Osteoarthritis Pain Product Portfolio
-
11.18.5 Recent Research and Development Strategies
12 Global Medicine for Osteoarthritis Pain Market Outlook by Types and Applications to 2028
-
12.1 Global Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global External Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Medical Care Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Personal Care Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Medicine for Osteoarthritis Pain Market Analysis and Outlook to 2028
-
13.1 Global Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.2.2 Canada Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.2.3 Mexico Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.3.2 UK Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.3.3 Spain Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.3.4 Belgium Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.3.5 France Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.3.6 Italy Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.3.7 Denmark Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.3.8 Finland Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.3.9 Norway Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.3.10 Sweden Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.3.11 Poland Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.3.12 Russia Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.3.13 Turkey Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.4.2 Japan Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.4.3 India Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.4.4 South Korea Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.4.8 Thailand Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.4.9 Singapore Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.4.11 Philippines Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.5.2 Colombia Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.5.3 Chile Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.5.4 Argentina Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.5.6 Peru Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.6.3 Oman Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.6.4 Qatar Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.7.2 South Africa Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.7.3 Egypt Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.7.4 Algeria Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Medicine for Osteoarthritis Pain
-
Figure of Medicine for Osteoarthritis Pain Picture
-
Table Global Medicine for Osteoarthritis Pain Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Medicine for Osteoarthritis Pain Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Injection Consumption and Growth Rate (2017-2022)
-
Figure Global External Consumption and Growth Rate (2017-2022)
-
Figure Global Medical Care Consumption and Growth Rate (2017-2022)
-
Figure Global Personal Care Consumption and Growth Rate (2017-2022)
-
Figure Global Medicine for Osteoarthritis Pain Consumption by Country (2017-2022)
-
Table North America Medicine for Osteoarthritis Pain Consumption by Country (2017-2022)
-
Figure United States Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Canada Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Mexico Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Table Europe Medicine for Osteoarthritis Pain Consumption by Country (2017-2022)
-
Figure Germany Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure UK Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Spain Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Belgium Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure France Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Italy Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Denmark Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Finland Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Norway Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Sweden Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Poland Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Russia Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Turkey Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Table APAC Medicine for Osteoarthritis Pain Consumption by Country (2017-2022)
-
Figure China Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Japan Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure India Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure South Korea Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Thailand Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Singapore Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Philippines Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Table South America Medicine for Osteoarthritis Pain Consumption by Country (2017-2022)
-
Figure Brazil Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Colombia Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Chile Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Argentina Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Peru Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Table GCC Medicine for Osteoarthritis Pain Consumption by Country (2017-2022)
-
Figure Bahrain Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Oman Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Qatar Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Table Africa Medicine for Osteoarthritis Pain Consumption by Country (2017-2022)
-
Figure Nigeria Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure South Africa Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Egypt Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Algeria Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Table Oceania Medicine for Osteoarthritis Pain Consumption by Country (2017-2022)
-
Figure Australia Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Table Mylan Company Details
-
Table Mylan Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Medicine for Osteoarthritis Pain Main Business and Markets Served
-
Table Mylan Medicine for Osteoarthritis Pain Product Portfolio
-
Table Bayer Company Details
-
Table Bayer Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Medicine for Osteoarthritis Pain Main Business and Markets Served
-
Table Bayer Medicine for Osteoarthritis Pain Product Portfolio
-
Table TEVA Company Details
-
Table TEVA Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table TEVA Medicine for Osteoarthritis Pain Main Business and Markets Served
-
Table TEVA Medicine for Osteoarthritis Pain Product Portfolio
-
Table Iroko Pharmaceuticals Company Details
-
Table Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Main Business and Markets Served
-
Table Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Product Portfolio
-
Table Johnson & Johnson Company Details
-
Table Johnson & Johnson Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Medicine for Osteoarthritis Pain Main Business and Markets Served
-
Table Johnson & Johnson Medicine for Osteoarthritis Pain Product Portfolio
-
Table Abiogen Pharma Company Details
-
Table Abiogen Pharma Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abiogen Pharma Medicine for Osteoarthritis Pain Main Business and Markets Served
-
Table Abiogen Pharma Medicine for Osteoarthritis Pain Product Portfolio
-
Table Astellas Pharma Company Details
-
Table Astellas Pharma Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Medicine for Osteoarthritis Pain Main Business and Markets Served
-
Table Astellas Pharma Medicine for Osteoarthritis Pain Product Portfolio
-
Table Horizon Pharma Company Details
-
Table Horizon Pharma Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Horizon Pharma Medicine for Osteoarthritis Pain Main Business and Markets Served
-
Table Horizon Pharma Medicine for Osteoarthritis Pain Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Medicine for Osteoarthritis Pain Main Business and Markets Served
-
Table Pfizer Medicine for Osteoarthritis Pain Product Portfolio
-
Table GlaxoSmithKline Company Details
-
Table GlaxoSmithKline Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Medicine for Osteoarthritis Pain Main Business and Markets Served
-
Table GlaxoSmithKline Medicine for Osteoarthritis Pain Product Portfolio
-
Table Hengrui Pharmaceutical Company Details
-
Table Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Main Business and Markets Served
-
Table Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Medicine for Osteoarthritis Pain Main Business and Markets Served
-
Table Novartis Medicine for Osteoarthritis Pain Product Portfolio
-
Table Abbott Company Details
-
Table Abbott Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Medicine for Osteoarthritis Pain Main Business and Markets Served
-
Table Abbott Medicine for Osteoarthritis Pain Product Portfolio
-
Table Tide Pharmaceutical Company Details
-
Table Tide Pharmaceutical Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tide Pharmaceutical Medicine for Osteoarthritis Pain Main Business and Markets Served
-
Table Tide Pharmaceutical Medicine for Osteoarthritis Pain Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Medicine for Osteoarthritis Pain Main Business and Markets Served
-
Table Sanofi Medicine for Osteoarthritis Pain Product Portfolio
-
Table Eli Lilly Company Details
-
Table Eli Lilly Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Medicine for Osteoarthritis Pain Main Business and Markets Served
-
Table Eli Lilly Medicine for Osteoarthritis Pain Product Portfolio
-
Table Daiichi Sankyo Company Details
-
Table Daiichi Sankyo Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo Medicine for Osteoarthritis Pain Main Business and Markets Served
-
Table Daiichi Sankyo Medicine for Osteoarthritis Pain Product Portfolio
-
Table Almatica Pharma Company Details
-
Table Almatica Pharma Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Almatica Pharma Medicine for Osteoarthritis Pain Main Business and Markets Served
-
Table Almatica Pharma Medicine for Osteoarthritis Pain Product Portfolio
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global External Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Medical Care Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Personal Care Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Medicine for Osteoarthritis Pain Consumption Forecast by Country (2022-2028)
-
Table North America Medicine for Osteoarthritis Pain Consumption Forecast by Country (2022-2028)
-
Figure United States Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Medicine for Osteoarthritis Pain Consumption Forecast by Country (2022-2028)
-
Figure Germany Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Medicine for Osteoarthritis Pain Consumption Forecast by Country (2022-2028)
-
Figure China Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Medicine for Osteoarthritis Pain Consumption Forecast by Country (2022-2028)
-
Figure Brazil Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Medicine for Osteoarthritis Pain Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Medicine for Osteoarthritis Pain Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Medicine for Osteoarthritis Pain Consumption Forecast by Country (2022-2028)
-
Figure Australia Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
